No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives
-
Antineoplastic Agents / pharmacology*
-
Axl Receptor Tyrosine Kinase
-
Caspases / metabolism*
-
Dose-Response Relationship, Drug
-
Drug Evaluation, Preclinical
-
Drug Therapy, Combination
-
Humans
-
Hydrazones / pharmacology*
-
Inhibitory Concentration 50
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell / metabolism*
-
Piperazines / pharmacology*
-
Piperidines
-
Proto-Oncogene Proteins / antagonists & inhibitors*
-
Pyrazoles / pharmacology*
-
Pyrimidines / pharmacology*
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Sulfonamides / pharmacology*
-
Tumor Cells, Cultured
Substances
-
2-(4-(4-(benzyloxy)benzyl)piperazin-1-yl)-N'-(3,5-di-tert-butyl-2-hydroxybenzylidene)acetohydrazide
-
Antineoplastic Agents
-
Hydrazones
-
Piperazines
-
Piperidines
-
Proto-Oncogene Proteins
-
Pyrazoles
-
Pyrimidines
-
Sulfonamides
-
dubermatinib
-
ibrutinib
-
Receptor Protein-Tyrosine Kinases
-
Caspases
-
Adenine
-
Axl Receptor Tyrosine Kinase
-
AXL protein, human